跳至主要内容
临床试验/NCT04792307
NCT04792307Unknown不适用

Feasibility RCT of Neuromuscular Electrical Stimulation; an Intervention to Maintain and Improve neuroMuscular Function During Periods of Immobility

Nottingham University Hospitals NHS Trust0 个研究点目标入组 66 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
66
主要终点
Elderly Mobility Scale

研究概览

简要总结

In this study, the investigators will use feasibility RCT design to determine whether it is justifiable to conduct a large-scale clinical trial of neuromuscular electrical stimulation with or without additional protein supplementation in hospitalised patients who are temporarily immobilised following a fragility fracture. Muscle thickness, muscle strength, patients' mobility and self-care will be assessed at baseline and after 6-wk trial duration or until patients discharged from hospital. Outcomes will include participants' recruitment rate, tolerability and accessibility and their characteristics.

详细描述

In frail elderly people with existing sarcopenia, muscle mass, muscle strength and muscle function during immobility after lower limb fractures are impaired and affect their functional abilities to achieve activities of daily living. To reverse these consequences, limited intervention studies show that resistance exercise training and protein supplement at least partly reverses sarcopenia. However, guidelines do not currently advise specific protein supplementation as a treatment to prevent or reverse sarcopenia. Additionally, these exercises are difficult to perform in adequate intensity when patients are ill, tired, or in pain and these same factors may reduce appetite. In this study, the investigators aim to evaluate the effect of neuromuscular electrical stimulation with and without a high protein oral nutritional supplement.

Methods:

In this study, the investigators will use feasibility RCT design to determine whether it is justifiable to conduct a large-scale clinical trial of neuromuscular electrical stimulation with or without additional protein supplementation in hospitalised patients who are temporarily immobilised following a fragility fracture. Muscle thickness, muscle strength, patients' mobility and self-care will be assessed at baseline and after 6-wk trial duration or until patients discharged from hospital. Outcomes will include participants' recruitment rate, tolerability and accessibility and their characteristics.

Discussion This study addresses the effects of neuromuscular electrical stimulation with or without high protein supplements on mobility, self-care, muscle mass and strength in immobile older people with frailty after lower limb fracture. The information from this study may justify a large-scale clinical trial of using electrical stimulation with or without high protein supplement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • >/=65 years
  • Hospitalised due to incident fragility fracture (hip, spine, pelvis, rib, upper limb, lower limb)
  • Immobile 72 hours after admission or completion of surgery whichever is the later.
  • Predicted date of discharge >/= 7 days after recruitment

排除标准

  • Unable to give valid informed consent
  • Residence outside catchment area of hospital (likely to be moved during the study period)
  • Unable to communicate in English sufficiently to participate in neuromuscular electrical stimulation.
  • Implanted medical device (e.g. pacemaker)
  • Any other contraindications to neuromuscular electrical stimulation (e.g. injury to the stimulation sites)
  • Leg amputation or any pre-injury conditions affecting a leg unilaterally such as hemiparesis
  • Dysphagia for liquids
  • Protein supplementation clinically indicated and prescribed
  • End stage renal failure
  • Obesity (BMI>30)
  • End of life, for any reason
  • Any other clinical reason why rehabilitation is not clinically indicated
  • Within 10 days of being symptom free having been COVID-19 positive (PCR testing or clinical criteria), or other barrier nursed patients
  • Lactose intolerance

结局指标

主要结局

Elderly Mobility Scale

时间窗: "Change from Baseline functional independence at 6 weeks"and " 6 months"

measuring 9 domains from very fit 1 to terminally ill 9

Lower limb muscle strength

时间窗: "Change from Baseline lower limb muscle strength at 6 weeks"

using A hand-held dynamometer for both vastus lateralis and tibialis anterior muscles

Disability and functional independence using Barthel ADL score.

时间窗: Change from Baseline functional independence at 6 weeks "and " 6 months"]

an ordinal scale used to measure performance in activities of daily living (ADL). variables describing ADL and mobility are scored, a higher number being a reflection of greater ability to function independently following hospital discharge.

Nottingham Extended ADL

时间窗: "Change from Baseline functional independence at 6 weeks"and " 6 months"

The Answers to the questions should be given whenever possible by the person who is the subject of the questionnaire Answers should be recorded by ticking one box for each question

Ultrasound

时间窗: "Change from Baseline lower limb muscle thickness at 6 weeks"

Ultrasound parameters of vastus lateralis and tibialis anterior muscles (thickness, pennation angle, echogenicity).

iEMG derived motor unit structure and function

时间窗: "Change from Baseline lower limb muscle control at 6 weeks"

intramuscular electromyography (iEMG) measures of muscle control

Hand grip strength

时间窗: "Change from Baseline Hand grip strength at 6 weeks"

using a standard device

次要结局

  • Tolerability measurement("up to 6 weeks")
  • Acceptability verbal questionnaire of Neuromuscular stimulation("up to 6 weeks")
  • Number of treatment sessions of Neuromuscular stimulation("up to 6 weeks")
  • Mortality Rate(At 6 months after recruitment)
  • Pain/Visual analogue scores("Change from Baseline functional independence at 6 weeks ")
  • Number of protein supplementation doses consumed("up to 6 weeks")
  • Duration of treatment sessions of Neuromuscular stimulation("up to 6 weeks")

研究者

申办方类型
Other
责任方
Sponsor

相似试验